Search Page

1

Cite

Share

Gastroprotective Effects of Polyphenols against Various Gastro-Intestinal Disorders: A Mini-Review with Special Focus on Clinical Evidence.

Chiu HF, Venkatakrishnan K, Golovinskaia O, Wang CK. Chiu HF, et al. Among authors: venkatakrishnan k. Molecules. 2021 Apr 6;26(7):2090. doi: 10.3390/molecules26072090. Molecules. 2021. PMID: 33917379 Free PMC article. Review.

Cite

Share

2

Cite

Share

Triterpenoids and polysaccharide peptides-enriched Ganoderma lucidum: a randomized, double-blind placebo-controlled crossover study of its antioxidation and hepatoprotective efficacy in healthy volunteers.

Chiu HF, Fu HY, Lu YY, Han YC, Shen YC, Venkatakrishnan K, Golovinskaia O, Wang CK. Chiu HF, et al. Among authors: venkatakrishnan k. Pharm Biol. 2017 Dec;55(1):1041-1046. doi: 10.1080/13880209.2017.1288750. Pharm Biol. 2017. PMID: 28183232 Free PMC article. Clinical Trial.

Cite

Share

3

Cite

Share

Reverse Translation: The Art of Cyclical Learning.

Kasichayanula S, Venkatakrishnan K. Kasichayanula S, et al. Among authors: venkatakrishnan k. Clin Pharmacol Ther. 2018 Feb;103(2):152-159. doi: 10.1002/cpt.952. Clin Pharmacol Ther. 2018. PMID: 29313963

Cite

Share

4

Cite

Share

Effect of severe renal impairment on the pharmacokinetics of brigatinib.

Gupta N, Hanley MJ, Kerstein D, Tugnait M, Narasimhan N, Marbury TC, Venkatakrishnan K. Gupta N, et al. Among authors: venkatakrishnan k. Invest New Drugs. 2021 Oct;39(5):1306-1314. doi: 10.1007/s10637-021-01095-5. Epub 2021 Mar 20. Invest New Drugs. 2021. PMID: 33742299 Free PMC article. Clinical Trial.

Cite

Share

5

Cite

Share

Model-Informed Drug Development for Ixazomib, an Oral Proteasome Inhibitor.

Gupta N, Hanley MJ, Diderichsen PM, Yang H, Ke A, Teng Z, Labotka R, Berg D, Patel C, Liu G, van de Velde H, Venkatakrishnan K. Gupta N, et al. Among authors: venkatakrishnan k. Clin Pharmacol Ther. 2019 Feb;105(2):376-387. doi: 10.1002/cpt.1047. Epub 2018 Mar 23. Clin Pharmacol Ther. 2019. PMID: 29446068 Free PMC article. Review.

Cite

Share

6

Cite

Share

Model-Informed Drug Development: Connecting the Dots With a Totality of Evidence Mindset to Advance Therapeutics.

Venkatakrishnan K, van der Graaf PH. Venkatakrishnan K, et al. Clin Pharmacol Ther. 2021 Nov;110(5):1147-1154. doi: 10.1002/cpt.2422. Clin Pharmacol Ther. 2021. PMID: 34658027 No abstract available.

Cite

Share

7

Cite

Share

The Changing Face of Oncology Research, Drug Development, and Clinical Practice: Toward Patient-Focused Precision Therapeutics.

Venkatakrishnan K, van der Graaf PH, Holstein SA. Venkatakrishnan K, et al. Clin Pharmacol Ther. 2020 Sep;108(3):399-404. doi: 10.1002/cpt.1979. Clin Pharmacol Ther. 2020. PMID: 33439492 No abstract available.

Cite

Share

8

Cite

Share

Chemopreventive and Chemotherapeutic Effect of Propolis and Its Constituents: A Mini-review.

Chiu HF, Han YC, Shen YC, Golovinskaia O, Venkatakrishnan K, Wang CK. Chiu HF, et al. Among authors: venkatakrishnan k. J Cancer Prev. 2020 Jun 30;25(2):70-78. doi: 10.15430/JCP.2020.25.2.70. J Cancer Prev. 2020. PMID: 32647648 Free PMC article. Review.

Cite

Share

9

Cite

Share

Quantitative Translation in Immuno-Oncology Research and Development.

Bottino D, Liu R, Bazzazi H, Venkatakrishnan K. Bottino D, et al. Among authors: venkatakrishnan k. Clin Pharmacol Ther. 2020 Sep;108(3):430-433. doi: 10.1002/cpt.1936. Epub 2020 Jul 9. Clin Pharmacol Ther. 2020. PMID: 32645203 Free PMC article. No abstract available.

Cite

Share

10

Cite

Share

Clinical Pharmacology of Ixazomib: The First Oral Proteasome Inhibitor.

Gupta N, Hanley MJ, Xia C, Labotka R, Harvey RD, Venkatakrishnan K. Gupta N, et al. Among authors: venkatakrishnan k. Clin Pharmacokinet. 2019 Apr;58(4):431-449. doi: 10.1007/s40262-018-0702-1. Clin Pharmacokinet. 2019. PMID: 30117017 Free PMC article. Review.

Cite

Share